Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00442936
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2007-02-28
Brief Title:
Study of Telcagepant MK-0974 in Participants With Moderate to Severe Acute Migraine With or Without Aura MK-0974-011
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Multicenter Double-Blind Placebo-Controlled Parallel Group Study to Compare the Response to a Single Treatment With Oral MK0974 With Placebo and Comparator in Subjects With Moderate to Severe Acute Migraine With or Without Aura
Status:
COMPLETED
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the efficacy and safety of telcagepant MK-0974 compared to an approved medication for acute migraine This study was conducted as a triple-dummy design for each dose of study drug participants each received 3 forms of study drug 2 capsules of active andor placebo and 1 tablet of active andor placebo and were instructed to take one of each form of study drug at dosing time
The primary hypotheses of this study are that telcagepant is superior to placebo in Pain Freedom at 2 Hours Post-Dose Pain Relief at 2 Hours Post-Dose Absence of Photophobia at 2 Hours Post-Dose Absence of Phonophobia at 2 Hours Post-Dose and Absence of Nausea at 2 Hours Post-Dose
The primary hypotheses of this study are that telcagepant is superior to placebo in Pain Freedom at 2 Hours Post-Dose Pain Relief at 2 Hours Post-Dose Absence of Photophobia at 2 Hours Post-Dose Absence of Phonophobia at 2 Hours Post-Dose and Absence of Nausea at 2 Hours Post-Dose
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006_525 | OTHER | Telerx ID Number | None |
| MK-0974-011 | OTHER | None | None |